Pain Relief with Zidolam N 300mg/150mg/200mg Tablets for Effective Management

Zidolam N 300mg/150mg/200mg Tablet

Description:

• Contains the active ingredients Lamivudine, Nevirapine, and Zidovudine.
• A combination of three antiretroviral medicines.
• Used to treat HIV-1 infection.

Important Information:

• Not advised for patients with anemia (low red blood cells) or neutropenia (low white blood cells).
• Inform your doctor if you have liver disease, including hepatitis B or C, kidney disease, or are overweight.
• The medication is not recommended for children less than 35 kg.
• May cause decreased fertility in females.
• Not recommended if you are allergic to this drug or any other active substance, or if you are pregnant or breastfeeding.

Therapeutic Effects:

• Lamivudine and Zidovudine inhibit the reverse transcriptase enzyme of HIV, restricting viral genome replication and reducing the production of new infectious viral particles.
• Nevirapine directly binds to reverse transcriptase (RT) and blocks RNA-dependent and DNA-dependent polymerase activities by disrupting the enzyme.

Interaction with Other Drugs:

• Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional supplements, and herbal products.
• Certain medications may exacerbate the toxicity of Zidovudine or reduce the effectiveness of Zidolam N.

Storage:

• Store Zidolam N below 30°C.
• Keep the medicine out of reach of children and pets.

How to Consume:

• Take as advised by your physician.
• Swallow the tablets whole and intact.
• Take with food.
• Do not crush, chew, or open the medicine.
• Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

Safety Advices:

• Pregnancy: Do not take if you are in your first trimester. Consult your physician if you are pregnant, suspecting, or planning to get pregnant during treatment.
• Breastfeeding: Breastfeeding is not recommended during treatment.
• Lungs: It is unknown whether Zidolam N is safe for patients with lung diseases. Consult your physician if you have any lung diseases.
• Liver: Use cautiously in patients with liver diseases. Dose adjustments are necessary.
• Alcohol: It is unknown whether consuming alcohol while taking Zidolam N is safe. Consult your physician.
• Driving: It is unknown whether Zidolam N alters the ability to drive or operate heavy machinery. If you feel sleepy or dizzy, avoid driving and consult your doctor.

Side Effects:

• Serious: Lactic acidosis, severe skin reactions, liver problems, osteonecrosis, symptoms of muscle weakness or infection, loss of fat from legs, face, and arms.
• Common: Nausea, diarrhea, headache, dizziness, cough, difficulty sleeping.

FAQs:

• Q1: Can I stop taking Zidolam N once I feel better?
  • A: No, continuing as prescribed is important, even if you feel better. Stopping or interrupting treatment can lead to viral rebound and the development of drug resistance.
• Q2: Can Zidolam N cure HIV?
  • A: No, Zidolam N cannot cure HIV. They are used as part of combination antiretroviral therapy (ART) to suppress the virus, improve the immune system, and prevent the progression of HIV infection. ART is a lifelong treatment for HIV.
• Q3: Can Zidolam N prevent HIV transmission during unprotected sex?
  • A: While Zidolam N is effective in managing HIV infection, they are not intended to prevent HIV transmission. It is necessary to use preventive measures like condoms to reduce the chance of acquiring HIV.
• Q4: Does Zidolam N cause bone marrow suppression?
  • A: Yes, Zidolam N may cause bone marrow suppression. Inform your physician if you experience any changes in your blood reports, such as increased or decreased RBC and WBC.
• Q5: Can Zidolam N be given to kidney failure patients?
  • A: Zidolam N should be used with caution in patients with kidney diseases. Inform your physician if you have any kidney diseases before initiating treatment.

Fact Box:

• Molecule name: Lamivudine + Nevirapine + Zidovudine
• Therapeutic class: Anti-retroviral
• Pharmacological class:
  • Lamivudine + Zidovudine - Nucleoside reverse transcriptase inhibitor (NRTI)
  • Nevirapine - Non-nucleoside reverse transcriptase inhibitor (Non-NRTI)
• Indications: HIV-1 infection

Tags: zidolam, painkiller, analgesic, antiinflammatory, pharmaceutical, medication